Prolonged cognitive deficits (“brain fog”) following COVID19 infection (long-COVID) are common and debilitating, yet there are currently no approved treatments. Cognitive impairment particularly targets the working memory and executive functions of the prefrontal cortex (PFC). The PFC has unusual neurotransmission and neuromodulation that render it vulnerable to stressors, and basic research has identified mechanisms that…
Neuroimmunology Reports Template
Write in a clean editor, then format for Neuroimmunology Reports in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Neuroimmunology Reports format
Neuroimmunology Reports is a peer-reviewed journal published by Elsevier, covering Peripheral Neuropathies and Disorders, Multiple Sclerosis Research Studies, Autoimmune Neurological Disorders and Treatments.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Neuroimmunology Reports 12 (2023) 45–58.
Formats any DOI in Neuroimmunology Reports style. No sign-up. |
| Publishes research in | Peripheral Neuropathies and Disorders Multiple Sclerosis Research Studies Autoimmune Neurological Disorders and Treatments Polyomavirus and related diseases Long-Term Effects of COVID-19 |
| ISSN | 2667-257X |
| Citation impact (2-yr) | 0.64 |
| h-index | 9 |
| i10-index | 8 |
| Total citations | 517 |
| Article processing charge | $2,000 |
| Top institutions publishing here | Harvard University |
| Journal website | www.sciencedirect.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Neuroimmunology Reports per year
Citation impact of Neuroimmunology Reports by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Neuroimmunology Reports
there are very few reports of COVID-19 vaccine related multiple sclerosis (MS) relapses. Here we report our first case of ChAdOx1 nCoV-19 Corona virus vaccine related MS relapse. a 24- year- old lady doctor, who had taken ChAdOx1 nCoV-19 Corona virus vaccine got a relapse after seven days of the last dose (second) of the…
Background Vaccinations against SARS-CoV-2 have been a topic of political, social, and medical intrigue since the declaration of the COVID-19 pandemic in early 2020. The vaccine side effects have been relatively mild to date, with few observed systemic effects. Case presentation A 69-year-old previously healthy female presented with symptoms of asymmetric bilateral lower and upper…
Since the declaration of COVID-19 pandemic, several cases of demyelination of both peripheral and central nervous systems have been reported. The association of viral infection and the development of CNS demyelination has long been studied, and this link has recently been reported following SARS-CoV-2 infection as well. We report a case of a 36-year-old male…
Unilateral cerebral cortical encephalitis (UCCE) with myelin oligodendrocyte glycoprotein (MOG) antibody comprises a new spectrum of disease entities that are characterized by unilateral cerebral cortical T2-weighted fluid-attenuated inversion recovery (T2 FLAIR) hyperintense lesions on MRI. In this retrospective study, the brain MRI of 39 consecutive Japanese patients with anti-MOG antibody-associated UCCE was examined. We found…